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Introduction: Pathologists currently diagnose breast lesions through histologic assessment, which requires fixation and
tissue preparation. The diagnostic criteria used to classify breast lesions are qualitative and subjective, and inter-observer
discordance has been shown to be a significant challenge in the diagnosis of selected breast lesions, particularly for
borderline proliferative lesions. Thus, there is an opportunity to develop tools to rapidly visualize and quantitatively
interpret breast tissue morphology for a variety of clinical applications.
Methods: Toward this end, we acquired images of freshly excised breast tissue specimens from a total of 34 patients
using confocal fluorescence microscopy and proflavine as a topical stain. We developed computerized algorithms to
segment and quantify nuclear and ductal parameters that characterize breast architectural features. A total of 33
parameters were evaluated and used as input to develop a decision tree model to classify benign and malignant breast
tissue. Benign features were classified in tissue specimens acquired from 30 patients and malignant features were
classified in specimens from 22 patients.
Results: The decision tree model that achieved the highest accuracy for distinguishing between benign and malignant
breast features used the following parameters: standard deviation of inter-nuclear distance and number of duct
lumens. The model achieved 81 % sensitivity and 93 % specificity, corresponding to an area under the curve of 0.93
and an overall accuracy of 90 %. The model classified IDC and DCIS with 92 % and 96 % accuracy, respectively. The
cross-validated model achieved 75 % sensitivity and 93 % specificity and an overall accuracy of 88 %.
Conclusions: These results suggest that proflavine staining and confocal fluorescence microscopy combined with
image analysis strategies to segment morphological features could potentially be used to quantitatively diagnose
freshly obtained breast tissue at the point of care without the need for tissue preparation.Introduction
Breast cancer diagnosis is an intricate process, which re-
quires tissue procurement, rigorous tissue preparation and
histologic assessment whether it is in the context of core
needle biopsy diagnosis or surgical excision. Fixed tissue
samples are processed after harvesting and are evaluated
for presence and type of malignant breast tissue based on
standardized histologic criteria [1–4], which employ cyto-
logical and qualitative architectural features. Breast tumors
that are diagnosed as malignant in nature are graded using
different types of grading systems to categorize the tumors* Correspondence: rkortum@rice.edu
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article, unless otherwise stated.into groups to reflect their biology of progression. One of
the most widely used grading systems was developed by
Bloom and Richardson in 1957, which used only qualitative
criteria to evaluate breast lesions [2]. In 1991, Elston and
Ellis published the Nottingham modification to the Bloom
and Richardson grading system, which incorporated semi-
quantitative criteria to evaluate tubule formation, nuclear
pleomorphism, and mitotic count [4]. Extensive research
has been done to evaluate the rate of inter- and intra-
observer discordance using these grading systems for histo-
logic assessment of fixed breast tissue. While some studies
have shown that inter-observer agreement is high in the
majority of cases [5], other studies have shown that subject-
ive criteria can lead to inter-observer variation for margin
assessment and poor reproducibility in evaluation of
borderline and in situ lesions [6–11]. The availabilityle is distributed under the terms of the Creative Commons Attribution 4.0
ns.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
give appropriate credit to the original author(s) and the source, provide a
indicate if changes were made. The Creative Commons Public Domain
.org/publicdomain/zero/1.0/) applies to the data made available in this
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applied without subjecting the tissue to processing can
overcome the subjectivity of interpretation and may
reduce the inter- and intra-observer variability in the
histological evaluation of breast tissue [12]. Such tech-
niques could also be potentially useful in settings lack-
ing the human resources and equipment necessary to
perform standard histologic assessment, which can be
a challenge in many parts of the world [13].
In order to characterize quantitative criteria to clas-
sify breast architecture, several studies have described
segmentation algorithms based on nuclear [14–18] and
ductal [19–21] morphometry in images of fixed tissue
stained with hematoxylin and eosin (H&E) staining.
Additionally, some recent studies evaluated nuclear
morphometric parameters using wide-field fluorescence
microscopy [22] and micro-optical computed tomog-
raphy [23] to acquire images of breast tissue. Specific-
ally, wide-field fluorescence microscopy combined with
watershed segmentation to quantify nuclei found that
area fraction could distinguish between tumor and nor-
mal regions in excised rat mammary tissue with 97 %
accuracy [22]. Micro-optical computed tomography and
nuclear morphometry was used to compare variations
between human breast cell lines and found that nuclear
volumes increased from normal to metastatic breast
cells and that nuclei of abnormal cells contained more
nucleoli [23].
The idea of establishing quantitative criteria on fixed tis-
sue can be taken one step further to be applied directly to
intact specimens using other imaging modalities, which can
obviate the need for extensive tissue processing. Several
studies have already described the feasibility of imaging
breast tissue with confocal microscopy in a clinical setting,
[24–29]. Schiffhauer and colleagues showed that confocal
reflectance microscopy could be used to image benign and
malignant breast features and provide visual similarity to
H&E micrographs [26]. Abeytunge and colleagues demon-
strated that confocal fluorescence microscopy can be used
to rapidly acquire images of fresh tissue specimens between
1 and 2.5 cm2 in size [29]. Our group recently showed that
confocal fluorescence microscopy yields images with suffi-
cient detail to identify benign and malignant breast archi-
tecture in freshly excised tissue [24]. In another recent
study, we demonstrated that confocal fluorescence images
can be used to estimate percent tumor cellularity in core
needle biopsy specimens and can indicate the adequacy of
procured tissue for diagnosis and ancillary molecular and
immunophenotypic studies [25].
The goal of this work is to combine both quantitative
image processing techniques with optical microscopy of in-
tact breast tissue specimens for interpretation of breast tis-
sue at the point of care. The benefits of this approach are
minimal tissue processing, rapid diagnosis, and quantitativecriteria that could potentially reduce the subjectivity with
intra- and inter-observer variation in the evaluation of
breast histology. In this study, we combine clinical confocal
microscopy with a computerized image processing algo-
rithm to quantify both nuclear and ductal morphology of
breast tissue; we develop an algorithm using these parame-
ters to classify breast tissue as benign - negative for tumor -
or malignant - tumor tissue present. Although previous
studies have described evaluation of breast architecture in
histologic images [14–21], these studies only considered
either nuclear or ductal parameters. We show that com-
bining both yields improved diagnostic performance, par-
ticularly in the diagnosis of invasive ductal cancer (IDC)
and ductal carcinoma in situ (DCIS) The nuclear and
ductal parameters described in this study could potentially
be used for objective categorization of breast lesions.
Methods
Breast tissue acquisition and preparation
Fresh human breast tissue specimens from 34 patients were
acquired through a protocol approved by The University of
Texas MD Anderson Cancer Center and Rice University
Institutional Review Boards, and each participant gave
written informed consent. Fresh breast tissue was ac-
quired from patients undergoing surgery to excise a
clinically abnormal lesion. The procedure for tissue
preparation has been described previously [24]. In
brief, two tissue specimens - one grossly abnormal and
one grossly normal in appearance were acquired from
each patient for image acquisition and evaluation; each
specimen measured approximately 15 × 15 mm2 in
size, with thickness varying from 2 to 7 mm. Within
30 min of surgical excision, breast tissue specimens
were stained for 1 min in a solution of 0.01 % profla-
vine in 1X phosphate-buffered saline (PBS). Proflavine
is a nuclear contrast agent [30, 31], which has been
used to stain breast tissue, oral mucosa, Barrett’s
esophagus, cervical tissue, and sarcoma in previous
studies [24, 25, 32–37]. Following topical application
of proflavine, specimens were washed with 1X PBS and
then immediately imaged.
Image acquisition and evaluation
Confocal fluorescence images were acquired from multiple
sites within each specimen using a multi-wavelength scan-
ning confocal microscope (Vivascope 2500®, Caliber Imaging
and Diagnostics Inc., Andover, MA, USA) as described pre-
viously [24, 25, 38]. Following topical application of profla-
vine and the PBS wash, each tissue specimen was positioned
on the microscope stage and imaged using 2.1 ± 0.4 mW
power at 488 nm laser excitation, and the fluorescence was
detected in a band pass of 550 ± 44 nm with a 30× water
immersion lens. At these settings, the lateral and axial reso-
lution was 1.0 μm and 5.0 μm, respectively, in the center of
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posite image was created for both sides of each tissue
specimen. To create the composite image, images were
acquired from contiguous sites in a grid pattern (max-
imum area 12.2 × 12.2 mm2) over the surface of the
specimen at an approximate depth of 20 μm. Following
image acquisition, specimens were kept moist in 1X
PBS and were submitted for routine histologic prepar-
ation and fixation. Samples were stained with H&E and
fixed on microscope slides for histologic assessment.
A board-certified, breast pathologist (author S.
Krishnamurthy) viewed composite confocal images and
fixed tissue specimens stained with H&E using a conven-
tional light microscope to identify sites that corresponded
to the same approximate location in the specimen based on
similar image morphology. Specifically we selected in-focus
confocal microscope fields of view that contain representa-
tive examples of characteristic benign and malignant breast
features. Thus, at each site, a corresponding pair of confocal
and H&E images were available from a 750 × 750 μm2
field of view. At each site, the H&E images of fixed tissue
specimens were used as a reference standard to identify
breast architectural features that should be present in cor-
responding confocal images [1, 24]. Benign breast features
identified in reference H&E images included adipose and fi-
brous tissue, lobules, non-hyperplastic ducts, and ductal
hyperplasia. Malignant breast features identified in refer-
ence H&E images included: ductal carcinoma in situ
(DCIS), invasive ductal carcinoma (IDC), and invasive lobu-
lar carcinoma (ILC). Benign breast features were identified
in specimens acquired from 30 patients and malignant fea-
tures were identified in specimens from 22 patients.Nuclear segmentation and connected components
algorithms for identifying nuclei
A technique called maximally stable extremal regions
(MSER) was used to segment nuclei from confocal images
of proflavine-stained breast tissue. MSER has been used
previously in the image-processing community for auto-
matic reconstruction of three-dimensional scenes; here we
have adapted it to segment nuclei from high-resolution
fluorescence confocal microscopy images [39]. MSER em-
ploys intensity thresholding; however, no global or optimal
threshold is sought; rather all thresholds are tested and the
stability of the isolated connected components (i.e. nuclei)
is evaluated. All possible thresholds from 0 to 255 are ap-
plied to an image and the sets of connected components
(as well as their area) are stored (Fig. 1a-d). This yields a
data structure in which the area of each connected compo-
nent is stored as a function of the intensity threshold. Fi-
nally, the intensity thresholds which correspond to local
minima in the rate of change of the area function are se-
lected as thresholds producing MSER.In order to apply MSER to our images, five tuning pa-
rameters associated with MSER had to be selected. The
first two parameters, which included the minimum area
(MinArea) and maximum area (MaxArea) of the con-
nected components, are related to the expected size of
nuclei. These parameters were selected based on the
biologically expected range of nuclear diameters. Spe-
cifically, other groups have found nuclear volume to
range from approximately 200 to 1500 μm3, which cor-
responds to 7 to 14 μm in diameter [23]. Therefore,
MaxArea was set to 500 pixels, which corresponds to
19 μm in diameter, which is larger than the expected nu-
clear size for our images. MinArea was set to 35 pixels,
which corresponds to 5 μm in diameter, which is smaller
than the expected nuclear size for our images. The next
set of parameters is related to the intensity thresholds and
includes maximum variation (MaxVariation), minimum
diversity (MinDiversity), and Delta. MaxVariation is the
maximum variation allowed within a region that corre-
sponds to a potential nucleus. MinDiversity is employed if
there are two nested maximally stable regions. Specifically,
if the diversity between the two nested regions is less than
MinDiversity, then the nested region is removed. Lastly,
Delta is the stability threshold. The stability of a region is
defined as the relative variation of the region area when
the intensity is changed by Delta/2. These intensity pa-
rameters were systematically tuned through applying a
range of values to representative images in order to select
the best value for each parameter. Specifically, one input
parameter was varied over a wide range while other input
parameters were held constant. For each iteration, the area
fraction (AF) from representative images of tumor and
normal tissue was calculated and overlays of the features
isolated with that particular setting were displayed.
The values that led to the largest differences in AF be-
tween tumor and normal tissues, while isolating fea-
tures that approximately corresponded to nuclei or
nucleoli, were selected. An illustration of this tuning
approach can be found in Figure S1 in Additional file 1.
Specifically, MaxVariation was set equal to 2.5, MinDiver-
sity to 0.5, and Delta to 6. These parameter values are in
terms of relative intensity, which for our 8-bit images
ranges from 0 to 255.
After nuclei were isolated with MSER, a connected
components algorithm was applied in order to calculate
parameters such as nuclear density and diameter. In the
connected components algorithm, all touching or con-
nected pixels are assumed to belong to the same cell nu-
cleus. Parameters include nuclear density (the number
of nuclei in a unit area), area fraction (the total nuclear
area divided by the total area), minimum inter-nuclear
distance (the distance from a nucleus center to the next
closest nucleus center), and nuclear diameter (the length
of the major axis of each nucleus). Nuclear density and
Fig. 1 Algorithms for nuclear (a-d) and ductal (e-l) segmentation. Nuclear segmentation: a: Raw image acquired from confocal fluorescence microscope
with 750 × 750 μm2 field of view. b: Region of interest selected in confocal fluorescence image with 75 × 75 μm2 field of view. c: The maximally stable
extremal regions (MSER) algorithm applies thresholds from 0 to 255 to b. d: At each threshold, the MSER algorithm identifies nuclei as connected
components and selects “maximally stable” components with the lowest size variation. Ductal segmentation: e: Raw image acquired from confocal
fluorescence microscope with 750 × 750 μm2 field of view. f: Wiener lowpass filter and adaptive histogram equalization applied to e. g: The algorithm
converts E to a binary image using an interactive threshold tool. h: Objects below range of nuclear area are removed and then user selects a region of
interest (ROI) around ducts with an interactive polygon selection tool. i: The algorithm fills boundaries of ducts identified in (h) to segment the outer
boundaries of the duct. j: The algorithm selects the complement of (h) to segment the inner boundaries of the duct (lumen). k: Duct wall width is
measured by selecting the shortest distance from the outer to the inner duct boundaries (red lines). l: Ellipses are fitted to outer and inner duct boundaries.
e-j: Scale bar is 100 μm. k, l: Scale bar is 25 μm
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for each image, while the minimum inter-nuclear distance
(IND) and nuclear diameter represent vector variables – a
value is calculated for each nucleus in the image. In order
to consolidate the vector variables into a scalar value, sev-
eral summary statistics were evaluated, including mean,
median, mode, interquartile range, and standard deviation.Ductal segmentation algorithm and quantification of
ductal parameters
An algorithm was developed to measure ductal parame-
ters, which segments non-hyperplastic ducts, ductal
hyperplasia, and DCIS lesions based on the intensity of
proflavine staining (Fig. 1e-l). To reduce noise and in-
crease image contrast, a Wiener lowpass filter was first
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histogram equalization (CLAHE, Fig. 1f ). Images were
converted from grayscale to binary using a user-defined
threshold based on relative intensity. The mean thresh-
old used to segment ducts was 107 ± 27 (range: 52–168)
on a scale of 0 to 255 for 8-bit images (Fig. 1g). It was
not possible to select a universal threshold, because in
order to accurately segment ducts from surrounding tis-
sue, it is necessary to isolate both nuclei in the duct
walls and inter-nuclear space between them. The relative
intensity of these features differed between images due
to the variation in illumination power used for image ac-
quisition and the variation in proflavine staining. Areas
smaller than the upper threshold for cell nuclei (approxi-
mately equivalent to 280 μm2 or 500 pixels, with a diam-
eter of 19 μm [40]) were removed to avoid segmenting
individual nuclei outside of the duct walls. Individual
ducts were manually segmented using a user-defined
polygon selection tool to define architectural features
corresponding to breast ducts (Fig. 1h). After application
of the ductal segmentation algorithm, the binary con-
focal image showed the segmented duct walls (Fig. 1h)
and the outer and inner boundaries (Fig. 1i, j) of the
duct used to measure ductal parameters.
Following segmentation of ducts, a number of ductal
parameters were measured based on the properties of the
inner and outer duct boundaries. The outer boundary de-
fines the outer edge of the duct wall and the inner bound-
ary defines the inner edge of the duct wall; the lumen. The
width of the duct wall was measured at every pixel on the
outer edge of the duct wall. This was done by finding the
shortest distance between every point on the outer bound-
ary and the nearest point on the inner boundary (Fig. 1k).
Duct wall width was measured for each non-hyperplastic
duct, ductal hyperplasia, and DCIS lesion and the vector
of values were summarized by calculating the mean, me-
dian, mode, interquartile range, and standard deviation.
Other scalar parameters measured include the area of the
duct wall, area of the lumen, area of an ellipse approximat-
ing the duct wall, area of an ellipse approximating the
lumen, lengths of the major and minor axes for the duct
and the lumen, solidity of the duct and the lumen, and ec-
centricity of the duct and the lumen (Fig. 1l).
Statistical analysis and model building
Nuclear parameters were calculated for all sites (n = 259)
and ductal parameters were calculated for all sites that
contained ducts (n = 50), and the diagnostic performance
of each image parameter was individually assessed by de-
termining the classification accuracy. Two-class linear dis-
criminant analysis was performed to classify malignant
from benign breast architectural features based on each
individual nuclear or ductal parameter; receiver operator
characteristic (ROC) curves were constructed and areaunder the curve (AUC) was calculated for each ROC
curve. Sensitivity and specificity values were determined
at the optimal cutpoint. Parameters were sorted by accur-
acy for classification of neoplasia based on AUC values.
Boxplots were created for the parameters with the highest
AUCs. A Student t test for samples with unequal variances
was used to identify statistically significant differences be-
tween mean parameter values measured in benign and
malignant tissues. This analysis was performed to evaluate
individual nuclear and ductal parameters to incorporate
into a classification model.
Next we sought to develop a multivariate model to
yield optimal separation between benign and malignant
tissues. Toward that end, all 33 nuclear and ductal vari-
ables were used as input for a classification and regres-
sion tree (CART) function in Matlab. Decision trees
were constructed using the automated Matlab function
classregtree, which selects parameters and cutpoints that
lead to the optimal classification of benign and malig-
nant breast architectural features. Decision trees were
pruned to prevent a single nuclear or ductal from being
used at more than one node within the tree. Pruning
was also performed to prevent the number of categories
for classification of malignant breast features from ex-
ceeding three: the number of malignant tissue types
(IDC, ILC, and DCIS). After construction, decision tree
nodes were pruned by finding the next higher node
whose decision point led to two categories, one with a
majority of neoplastic sites, and one with a majority of
benign sites. A custom leave-one-out cross-validation al-
gorithm was also developed in order to calculate the
cross-validated sensitivity and specificity. Specifically,
258 of the 259 data points were used to build a CART
model, which contained the same two variables
at the first and second decision points. Specifically
the standard deviation of IND (StdIND) was the first
decision point and the number of lumens was the
second decision point. However, with each iteration of
leave-one-out cross-validation, the cutoff value of
StdIND could vary. The cutoff value associated with the
number of lumens (number of lumens >1) was held con-
stant because biologically normal ducts are expected to
only contain a single lumen; therefore, this was consid-
ered to be the optimal and only logical cutoff value and
therefore was held constant. Then the model was ap-
plied to the remaining data point, which was classified
as either benign or malignant. This process was repeated
for all 259 data points, and the calculated diagnosis for
each image was compared to the known diagnosis in order
to calculate sensitivity and specificity for the cross-
validated model. The performance of the decision tree
was characterized by computing sensitivity and specificity
for classification of malignant breast architectural features.
Additionally, sensitivity and specificity were calculated for
Fig. 2 Representative raw confocal fluorescence images of adipose tissue, fibrous tissue, lobules, invasive ductal carcinoma, and invasive lobular
carcinoma are shown in a through e, respectively. f-J: Nuclei segmented by identifying maximally stable extremal regions (MSER) are false colored
green and overlaid onto the raw confocal fluorescence image. k-o: Histologic slides with H&E staining show similar histology to confocal images in
a-e. Slides were prepared with the same specimens from which confocal images were acquired. Scale bar is 100 µm
Table 1 Summary of patients from which tissue specimens
were acquired, sites analyzed with segmentation algorithms,
and histologic diagnoses for each site
Diagnosis Patients Sites
Benign 30 179
Adipose tissue 18 42
Fibrous tissue 14 31
Lobules 12 82
Non-hyperplastic ducts 6 20
Hyperplastic ducts 4 4
Malignant 22 80
Ductal carcinoma in situ (DCIS) 6 26
Invasive ductal carcinoma (IDC) 15 37
Invasive lobular carcinoma (ILC) 3 17
Total 34 259
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to determine the relative classification accuracy for IDC,
ILC, and DCIS sites. For example, in order to calculate
sensitivity for IDC, true positives were defined as IDC
sites that had been classified as malignant by the decision
tree, and false negatives were defined as IDC sites that had
been classified as benign. Specificity was calculated by
defining true negatives as benign sites that were correctly
classified in the decision tree and false positives were
defined as benign sites that were incorrectly classified. An
ROC curve was constructed for the decision tree model.
All sites were sorted in order of ascending StdIND
value and then sensitivity and specificity for classification
of neoplasia were calculated at every StdIND value. The
cutoff value for number of lumens was held constant at
one lumen because biologically normal ducts are expected
to only contain a single lumen. AUC was calculated based
on the resulting ROC curve.
Results
A total of 259 sites from 34 patients were identified in
composite confocal fluorescence images. A summary of
patients, sites, and diagnoses are included in Table 1. In
total there were 179 benign sites, which included adi-
pose tissue, fibrous tissue, lobules, and benign ducts,and 80 malignant sites, which included DCIS, IDC, and
ILC.
Figure 2 shows representative confocal images of sites
without ducts acquired by confocal fluorescence micros-
copy (Fig. 2a-e), nuclei isolated with MSER at those sites
(Fig. 2f-j), and sites in the corresponding histologic slide
with H&E staining that have similar histology to the
Fig. 3 Representative confocal images of normal, non-hyperplastic ducts (a), hyperplastic ducts (b), and ductal carcinoma in situ (c) analyzed with the
nuclear segmentation algorithm (middle row) and with the ductal segmentation algorithm (bottom row). d-f: Nuclei segmented by identifying maximally
stable extremal regions (MSER) are false colored green and overlaid onto the raw confocal fluorescence image. g-i: Breast ducts segmented using the
ductal segmentation algorithm. j-l: Histologic slides with H&E staining show similar histology to confocal images in a-e. Slides were prepared with the
same specimens from which confocal images were acquired. Scale bar is 100 µm
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and overlaid onto the original images for visualization. As
seen, nuclei are isolated at the periphery of adipose cells
(Fig. 2f) and are dispersed throughout the fibrous tissue
image (Fig. 2g). Denser clusters of nuclei are isolated in and
around lobules (Fig. 2h). Nuclei are the most dense at sites
with malignant tissue, including IDC and ILC (Fig. 2i, j).
Figure 3 shows representative images of breast ducts ac-
quired with confocal fluorescence microscopy (Fig. 3a-c),
nuclei that were isolated at sites with breast ducts using
MSER (Fig. 3d-f), ducts that were segmented with theductal segmentation algorithm (Fig. 3g-i), and sites in the
corresponding histologic slide with H&E staining that
have similar histology to the confocal sites (Fig. 3j-l).
Nuclear density in and around the ducts increases from
the non-hyperplastic duct, to the hyperplastic duct, to
DCIS (Fig. 3d, e, f). However, relatively few nuclei are suc-
cessfully isolated using MSER within the non-hyperplastic
and hyperplastic ducts, which is most likely due to the fact
that the borders of individual nuclei are difficult to visually
discern in confocal fluorescence images. The images of
sites isolated with the ductal segmentation algorithm show
Fig. 4 Mean value of parameters used to separate malignant from benign sites. Nuclear parameters calculated with the nuclear segmentation algorithm
are shown for all adipose, fibrous, lobules, invasive ductal carcinoma (IDC), and invasive lobular carcinoma (ILC) sites; a: standard deviation of inter-nuclear
distance; b: area fraction; c: range of inter-nuclear distance. Ductal parameters calculated with the duct-based segmentation algorithm are shown for all
normal, non-hyperplastic ducts, hyperplastic ducts (Hyperplasia), and ductal carcinoma in situ (DCIS); d: number of lumens; e: minor dimension of outer
ellipse; f: area of outer ellipse. The number of sites represented in each box is represented by n. Significant differences between mean values of
parameters measured at benign and malignant sites are indicated by asterisks (*)
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hyperplastic duct (Fig. 3g and h). Conversely, the image of
DCIS shows bridges of cells crossing the lumen to create a
cribriform pattern with several lumens.
The parameters that yielded the highest performance
for distinguishing between benign and malignant sites
are shown in Table 2. We evaluated the performance of
nuclear parameters for classification of benign and ma-
lignant features in all sites and in subgroups of sites that
did or did not contain ducts to determine the groups for
which nuclear parameters had the highest classification
accuracy. We only evaluated the classification accuracy
of ductal parameters at sites that contained ducts. Nuclear
parameters measured at non-duct sites achieve higher per-
formance (AUC= 0.93) than nuclear parameter measured
at duct sites (AUC= 0.69). Conversely, ductal parameters
achieve higher performance (AUC= 0.92) than nuclear pa-
rameters for classification of duct sites (AUC= 0.69). These
findings suggest that a combination of nuclear parameters
measured at non-duct sites and ductal parameters mea-
sured at duct sites may yield improved separation between
all benign and malignant sites.Boxplots showing the mean and interquartile range
of the top three performing nuclear parameters are
shown in Fig. 4a-c. Both StdIND and Range IND de-
crease from adipose to fibrous to lobules to ILC to
IDC (Fig. 4a and c), while AF increases from adipose
to fibrous to lobules to ILC to IDC (Fig. 4b). This
trend suggests that the number of clusters of nuclei
increases from adipose tissue, which has the fewest, to
IDC, which has the greatest number of clusters of nu-
clei. All comparisons between benign (adipose, fibrous,
lobules) and malignant (IDC, ILC) sites were signifi-
cant. Similarly, AF increases from adipose to fibrous
to lobules to IDC (Fig. 4b), which suggests increasing
nuclear density.
Boxplots showing the mean and interquartile range of
the top three performing ductal parameters for duct sites
are shown in Fig. 4d-f. DCIS lesions have a significantly
higher number of lumens than hyperplastic and non-
hyperplastic ducts (p <0.001), which is consistent with
the cribriform pattern that occurs when abnormally high
cellular proliferation causes the luminal space to be filled
with epithelial cells (Fig. 4d). Figure 4e shows that the
Fig. 5 Classification tree automatically generated when all nuclei and duct data was used. Duct- and nuclei-based parameters selected by
classification regression tree analysis to optimize separation between benign and malignant sites. Bar graphs show the diagnoses of sites sorted
into each classification category
Table 2 Summary of top performing parameters for distinguishing between benign and malignant sites measured using the
nuclear and ductal segmentation algorithms
Group Performance metric Standard deviation
of inter-nuclear distance
Area fraction Range of inter-nuclear distance
A. Classification by nuclear
parameter – all sites
AUC 0.87 0.86 0.87
Sensitivity 78 76 76
Specificity 82 79 85
B. Classification by nuclear
parameter – non-duct sites
AUC 0.93 0.92 0.91
Sensitivity 85 80 81
Specificity 88 87 88
C. Classification by nuclear
parameter – duct sites
AUC 0.68 0.72 0.74
Sensitivity 46 65 62
Specificity 100 70 96
Group Performance metric Number of lumens Minor dimension of outer ellipse Area of outer ellipse
D. Classification by duct
parameter – duct sites
AUC 0.92 0.83 0.82
Sensitivity 88 73 81
Specificity 88 79 75
A: Nuclear parameters measured at all sites using the nuclear segmentation algorithm. B: Nuclear parameters measured at all sites except those with breast ducts
(normal ducts, hyperplastic ducts, and ductal carcinoma in situ) using the nuclear segmentation algorithm. C: Nuclear parameters measured at sites with breast
ducts using the nuclear segmentation algorithm. D: Ductal parameters measured at sites with breast ducts using the ductal segmentation algorithm. AUC area
under the curve
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Table 3 Performance of classification tree model for classification
of neoplasia, non-neoplasia, and individual histologic types of
breast neoplasia in confocal fluorescence images
Sensitivity Specificity
Classification tree model 81 % (65/80) 93 % (167/179)
Cross-validated model 75 % (60/80) 93 % (167/179)
Correctly classified
All sites 90 % (232/259)
Ductal carcinoma in situ (DCIS) 96 % (25/26)
Invasive ductal cancer (IDC) 92 % (34/37)
Invasive lobular carcinoma (ILC) 35 % (6/17)
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duct is significantly smaller in normal, non-hyperplastic
ducts than in DCIS lesions (p <0.001). There is no signifi-
cant difference in the minor dimension between ellipses
approximating hyperplastic ducts and DCIS lesions (Fig. 4e).
Figure 4f shows that the area of the outer ellipse approxi-
mating duct area was significantly smaller in normal, non-
hyperplastic ducts than in DCIS lesions (p <0.001).
There is no significant difference between the average
area of outer ellipses approximating hyperplastic ducts
and DCIS lesions (Fig. 4f ).
All 33 nuclear and ductal parameters were used as input
for a classification and regression tree (CART) algorithm to
automate selection of parameters to discriminate benign
and malignant sites. The CART algorithm was pruned to
remove redundancies and overfitting to the data set. The
classification tree generated through this process is shown
in Fig. 5. StdIND with a cutoff value of 6.83 μm is the first
decision point selected for classification by the decision
tree, followed by number of lumens with a cutoff value of
one. StdIND <6.83 μm separates out 52 true-positives com-
posed of IDC, DCIS, and ILC sites and nine false-positives
composed of fibrous and lobule sites. The remaining sites
enter the second node – number of lumens >1 – which
separates out 13 true-positive DCIS sites and three false-
positive hyperplasia and normal duct sites. The remaining
sites are classified as benign and are composed of 167 true-
negative adipose, fibrous, lobule, normal duct, and hyper-
plasia sites and 15 false-positive IDC, DCIS, and ILC sites.
Overall, the model achieved a sensitivity and specificity of
81 % and 93 % respectively, corresponding to an AUC of
0.93 and 90 % overall classification accuracy, as shown in
Table 3. If the model is evaluated based on classification of
individual histologic types of neoplasia, 92 % of IDC sites
and 96 % of DCIS sites were classified correctly. However,
the model correctly classified only 35 % of ILC sites. Add-
itionally, leave one out cross-validation was performed,
which yielded a cross-validated sensitivity of 75 % and spe-
cificity of 93 % (Table 3). Specifically, cross-validation re-
sulted in a 6 % drop in sensitivity (from 81 to 75 %) due to
the fact that five additional IDC images were incorrectly
classified during cross-validation. When each of these five
cases were left out of the original cohort of data used to
form the model (in other words during the leave-one-out
cross-validation exercise), the cutoff value associated with
StdIND dropped. This resulted in each of the five cases
being classified as a false negative. For the remainder of
the images, the cutoff value associated with StdIND
remained the same as it is in Fig. 5, resulting in the
same specificity of 93 %.
As seen in the histograms in Fig. 5, ILC sites account
for the largest number of false negatives (n = 11 out of
17 sites) while lobule sites account for the largest num-
ber of false positives (n = 8 out of 82 sites). Figure 6shows representative confocal images of a true-positive
ILC, false-negative ILC, true-negative lobules, and false-
positive lobules sites (Fig. 6a-d), nuclei isolated with
MSER at those sites (Fig. 6e-h), and sites in the corre-
sponding histologic slide with H&E staining that have
similar histology to the confocal sites (Fig. 6i-l). As seen,
there are large differences in the density and clustering
of nuclei between the true-positive ILC site (Fig. 6e) and
true-negative lobules site (Fig. 6g). In comparison to
Fig. 6e, the false-negative ILC site in Fig. 6f has relatively
few nuclei, which appear to be predominately clustered
in the upper left region of the image. Conversely, the
false-positive lobules site in Fig. 6h contains more nuclei
than Fig. 6g, particularly in stromal tissue located in be-
tween lobules.
Discussion
In this study, we performed quantitative analysis of
breast histology in confocal fluorescence images by de-
signing algorithms to segment and measure nuclear and
ductal parameters. We combined nuclear and ductal pa-
rameters to develop a classification tree model to classify
malignant from benign changes in the breast paren-
chyma with 81 % sensitivity and 93 % specificity, which
corresponded to an AUC of 0.93 and an overall accuracy
of 90 %. The cross-validated model classified the same
sites with 75 % sensitivity, 93 % specificity, and 88 %
overall accuracy.
Several groups have used automated morphometric
evaluation of nuclei in H&E-stained sections of breast tis-
sue [14–17], cytological smears of breast tissue [18], and
fluorescence microscopy images of mouse tissue [22, 37]
to classify benign and malignant breast features. While
these groups demonstrate that quantitative nuclear pa-
rameters can be used to classify benign and malignant
breast features, some lesions are more difficult to distin-
guish. For example, Rajesh et al. used automated nuclear
morphometry to classify ILC, IDC, and borderline lesions
[16]. While significant differences were found between pa-
rameters measured for ILC and IDC, no significant differ-
ence was found between parameters measured for ILC
Fig. 6 Representative images of sites with lowest classification accuracy in the decision tree model. a-d: Invasive lobular carcinoma and lobules in
confocal fluorescence images. e-h: Nuclei segmented by identifying maximally stable extremal regions (MSER) are false-colored green and overlaid
onto the raw confocal fluorescence image. i-l: Histologic slides with hematoxylin and eosin (H&E) staining show similar histology to confocal images in
(a-e). Slides were prepared with the same specimens from which confocal images were acquired. a, e: A true-positive invasive lobular carcinoma (ILC)
site; (b, f): false-negative ILC site; (c, g): true-negative lobules; and (d, h): false-positive lobules. Scale bar is 100 μm
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sults to the other studies – namely that ILC is difficult to
distinguish from non-neoplasia based on nuclear features
alone. Additionally, several studies have demonstrated the
feasibility of computerized image analysis to distinguish
between non-hyperplastic ducts, hyperplastic ducts, and
DCIS. Mayr et al. used computerized image analysis to
quantify ductal parameters in H&E-stained slides of breast
biopsies and found that the most significant parameters
for differentiation between normal ducts and DCIS were
duct mean diameter and the presence of necrosis [19].
Anderson et al. used a computerized segmentation algo-
rithm to measure parameters of ductal hyperplasia and
DCIS in tissue sections stained with the antibody cocktail
AE 1/3, and showed that the highest classification accur-
acy for DCIS was achieved by combining parameters of
ducts and lumina [20]. The findings from our work agreewith previous studies, which showed that quantitative
ductal parameters can be used to classify benign and ma-
lignant ducts [19, 20].
The strengths of our study are that we demonstrate that
nuclear and ductal parameters can be measured in con-
focal fluorescence images of clinical samples acquired at
the point of care. We perform quantitative analysis of
breast tissue architecture without requiring tissue fixation,
cutting, and staining and achieve comparable classification
accuracy to studies that performed computerized analysis
on fixed breast tissue stained with H&E. The model classi-
fied IDC and DCIS with greater than 90 % accuracy using
parameters that were based on the morphological charac-
teristics of each malignant tissue type. Specifically, IDC
was classified with 92 % accuracy using standard deviation
in inter-nuclear distance as a parameter, which identifies
dense clusters of nuclei. DCIS was classified with 96 %
Dobbs et al. Breast Cancer Research  (2015) 17:105 Page 12 of 14accuracy based on the presence of more than one lumen,
which is consistent with the cribriform pattern. Overall
we achieve high performance (AUC = 0.93) on a large
number of sites (n = 259).
There are several limitations associated with this
study. While our data set contains a large number of
sites (n = 259), the data were acquired at a single center,
and some individual categories, such as ILC contain
relatively few sites; therefore, additional work is needed
with a large, independent data set including samples
from more than one center to validate the reproducibil-
ity of these parameters. This is particularly important
given the large variance we observed in nuclear parame-
ters. The heterogeneity in nuclear area and distribution
within benign breast tissue is a potential source of vari-
ance for the nuclear parameters measured in this study.
Nuclear area and spacing in breast epithelia vary with a
number of conditions, including sexual maturity, preg-
nancy, menopausal status, use of hormonal contracep-
tives, as well as the presence of IDC and ILC [1, 2, 40, 41].
Despite this variation, leave-one-out cross-validation of
the CART model yields similar performance to the ori-
ginal model suggesting that our algorithm may generalize
to an independent data set.
In addition, the algorithm designed for ductal segmenta-
tion uses an interactive threshold to convert images from
grayscale to binary and a user-defined selection tool to iso-
late ducts from surrounding nuclei. The ductal segmenta-
tion process is a potential source of variability between
users, particularly for parameters that could be impacted by
a user’s visual assessment of the duct wall boundaries, such
as duct wall width. However, the ductal parameter that was
ultimately selected for the decision tree model was the
number of lumens, which is unlikely to vary at the decision
point (number of lumens greater than one) based on slight
variations to the threshold value or by excluding surround-
ing nuclei. This is because it is readily apparent if a duct
has one or more lumens based on visual assessment, how-
ever, the segmentation algorithm could assist in identifying
ducts with more than one lumen. Lastly, examination of
the breakdown of false negatives and false positives reveals
that our algorithm does most poorly at distinguishing ILC
and lobule sites. Specifically 65 % (n = 11 out of 17 sites) of
ILC sites and 10 % of lobule sites (n = 8 out of 82 sites) are
incorrectly classified. Figure 6 reveals that there are differ-
ences in quantity and clustering of nuclei between the true-
positive and false-negative ILC sites. In particular, nuclei in
the false-negative ILC site appear to be predominately lo-
cated in the upper left region of the image, suggesting that
only the upper left region of the image contains ILC while
the remainder of the image may contain other benign tis-
sue. Therefore, the fraction of the image that consists of a
malignant tissue type may correlate with the likelihood that
it is correctly classified as a true-positive site. Conversely,the false-positive lobule site contains more nuclei than the
true-negative lobule site, particularly in stromal tissue lo-
cated in between lobules. This indicates that the stromal
tissue that lobules or other features are embedded within
may lead to incorrect classification as a false-positive site.
In future studies, additional parameters are needed in order
to classify lobules as benign and ILC as malignant with
greater accuracy.
It is to be noted that while confocal microscopy pro-
vides high-resolution high-quality images, currently its
cost, footprint, and maintenance requirements limit the
ability to translate this imaging platform to routine usage
in patient care. However, this study lays the groundwork
for how quantitative analysis could be combined with
proflavine staining and fluorescence microscopy. Several
applications of fluorescence confocal microscopy can cer-
tainly evolve in pathology practice with the potential avail-
ability of a user friendly and affordable platform that can
be an alternate to currently used modalities for immediate
evaluation of fresh tissue. In addition, there could be an
opportunity to use a low-cost fluorescence confocal
microscope to obtain similar images that may be useful to
evaluate fresh tissues in clinical practices with limited re-
sources of professional pathology expertise and laboratory
infrastructure to obtain information from the biopsied tis-
sue to guide clinical management [38, 42].
Conclusions
We measured quantitative nuclear and ductal parameters
in confocal fluorescence images of proflavine-stained fresh
breast tissue and developed a classification algorithm that
distinguished between 259 benign and malignant sites
with an accuracy of 88 %. Ultimately, the nuclear and
ductal parameters described in this study could be used to
develop criteria to automate breast lesion diagnosis for
immediate evaluation of fresh tissue at the point of care
obviating the need for extensive tissue preparation. Quan-
titative diagnostic criteria developed on fluorescence con-
focal images in our study have the potential to enable
automated assessment of breast tissue.
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Additional file 1: Figure S1. Illustration of methodology used to select
MSER intensity parameters. The intensity parameters MaxVariation,
MinDiversity, and Delta were selected by varying each parameter one at
a time. The area fraction (AF) was calculated for each representative
image after each iteration of MSER. Each intensity parameter was plotted
as a function of AF. Values for the intensity parameters were selected
based on which values correctly isolated nuclei from the representative
images and which values led to the largest differences between tumor
and benign images. Scale bar 100 μm. (ZIP 140 kb)
Abbreviations
AF: area fraction; AUC: area under the curve; CART: classification and
regression tree; DCIS: ductal carcinoma in situ; H&E: hematoxylin and eosin;
Dobbs et al. Breast Cancer Research  (2015) 17:105 Page 13 of 14IDC: invasive ductal cancer; ILC: invasive lobular carcinoma; IND: inter-nuclear
distance; MaxArea: maximum area; MaxVariation: maximum variation;
MinArea: minimum area; MinDiversity: minimum diversity; MSER: maximally
stable extremal regions; PBS: phosphate-buffered saline; ROC: receiver
operator characteristic; StdIND: standard deviation of IND.
Competing interests
The corresponding author, Dr. Richards-Kortum, holds minority ownership of
Remicalm, LLC as a scientific advisor. Dr. Ramanujam has founded a company
called Zenalux Biomedical and she and other team members have developed
technologies related to this work where the investigators or Duke may benefit
financially if this system is sold commercially. The other authors declare that
they have no conflicts of interest.
Authors’ contributions
JD, JM, NR, RRK, and WY conceived and designed the experiments. JD
performed the experiments. DS, JD, and JM designed the computer
algorithms to analyze the data. JD and JM analyzed the data. JD and JM
wrote the manuscript. HK performed the surgical excision of clinically
abnormal lesions. SK gave a pathological diagnosis for tissue that was
imaged. SK and WY assisted with editing the manuscript. All authors read
and approved the final manuscript.
Acknowledgements
The authors would like to acknowledge support from the U.S. Department of
Defense Era of Hope Award W81XWH-09-1-0410, NIH Grant Number
1R01EB01157, and the Susan G. Komen for the Cure grant KG091020.
We thank Dr. Rebecca Willett for providing the MSER code and guidance on
the initial implementation.
Author Dongsuk Shin changed employment during the study. New
affiliation: The University of Texas Medical School at Houston, 6431 Fannin St,
Houston, TX 77030,USA.
Author details
1Department of Bioengineering, Rice University, 6500 Main Street, BRC 502,
Houston, TX 77030, USA. 2Department of Biomedical Engineering, Duke
University, 101 Science Drive, Room 136 Hudson Hall, Box 90281, Durham,
NC 27708, USA. 3Department of Pathology, University of Texas MD Anderson
Cancer Center, 1515 Holcombe Boulevard, Unit 1350, Houston, TX 77030,
USA. 4Department of Surgical Oncology, University of Texas MD Anderson
Cancer Center, 1515 Holcombe Boulevard, Unit 0444, Houston, TX 77030,
USA. 5Department of Diagnostic Radiology, University of Texas MD Anderson
Cancer Center, 1515 Holcombe Boulevard, Unit 1350, Houston, TX 77030,
USA.
Received: 6 April 2015 Accepted: 15 July 2015
References
1. Rosen PP. Rosen’s breast pathology. 3rd ed. Philadelphia, PA, USA:
Lippincott Williams & Wilkins; 2009.
2. Bloom HJ, Richardson WW. Histological grading and prognosis in breast
cancer; a study of 1409 cases of which 359 have been followed for 15 years.
Br J Cancer. 1957;11:359–77.
3. Silverberg SG. Atlas of breast pathology. Philadelphia, Pennsylvania, USA:
W.B. Saunders Company; 2002.
4. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The
value of histological grade in breast cancer: experience from a large study
with long-term follow-up. Histopathology. 1991;19:403–10.
5. Schnitt SJ, Connolly JL, Tavassoli FA, Fechner RE, Kempson RL, Gelman R, et al.
Interobserver reproducibility in the diagnosis of ductal proliferative breast
lesions using standardized criteria. Am J Surg Pathol. 1992;16:1133–43.
6. Delides GS, Garas G, Georgouli G, Jiortziotis D, Lecca J, Liva T, et al.
Intralaboratory variations in the grading of breast carcinoma. Arch Pathol
Lab Med. 1982;106:126–8.
7. Rosai J. Borderline epithelial lesions of the breast. Am J Surg Pathol.
1991;15:209–21.
8. Theissig F, Kunze KD, Haroske G, Meyer W. Histological grading of breast
cancer - interobserver, reproducibility and prognostic significance. Pathol Res
Practice. 1990;186:732–6.9. Meyer JS, Alvarez C, Milikowski C, Olson N, Russo I, Russo J, et al. Breast
carcinoma malignancy grading by Bloom-Richardson system vs proliferation
index: reproducibility of grade and advantages of proliferation index. Mod
Pathol. 2005;18:1067–78.
10. Frierson HF, Wolber RA, Berean KW, Franquemont DW, Gaffey MJ, Boyd JC, et al.
Interobserver reproducibility of the Nottingham modification of the Bloom and
Richardson histologic grading scheme for infiltrating ductal carcinoma. Am J Clin
Pathol. 1995;103:195–8.
11. Stenkvist B, Westmannaeser S, Vegelius J, Holmquist J, Nordin B, Bengtsson
E, et al. Analysis of reproducibility of subjective grading systems for breast
carcinoma. J Clin Pathol. 1979;32:979–85.
12. Gilchrist KW, Kalish L, Gould VE, Hirschl S, Imbriglia JE, Levy WM, et al.
Interobserver reproducibility of histopathological features in stage II breast
cancer - an ECOG study. Breast Cancer Res Treat. 1985;5:3–10.
13. Adeyi OA. Pathology services in developing countries-the West African
experience. Arch Pathol Lab Med. 2011;135:183–6.
14. Ladekarl M, Sørensen FB. Quantitative histopathological variables in in situ
and invasive ductal and lobular carcinomas of the breast. APMIS.
1993;101:895–903.
15. Ozaki D, Kondo Y. Comparative morphometric studies of benign and malignant
intraductal proliferative lesions of the breast by computerized image analysis.
Hum Pathol. 1995;26:1109–13.
16. Rajesh L, Dey P, Joshi K. Automated image morphometry of lobular breast
carcinoma. Anal Quant Cytol Histol. 2002;24:81–4.
17. Latson L, Sebek B, Powell KA. Automated cell nuclear segmentation in color
images of hematoxylin and eosin-stained breast biopsy. Anal Quant Cytol
Histol. 2003;25:321–31.
18. Gupta S, Gupta R, Singh S, Gupta K, Kaur CJ. Role of morphometry in
evaluation of cytologically borderline breast lesions: a study of 70 cases.
Diagn Cytopathol. 2012;40:191–6.
19. Mayr NA, Staples JJ, Robinson RA, VanMetre JE. Intraductal breast
carcinoma: initial results of a morphometric study using computerized
digital image analysis. Clin Oncol (R Coll Radiol). 1990;2:66–70.
20. Anderson NH, Hamilton PW, Bartels PH, Thompson D, Montironi R, Sloan
JM. Computerized scene segmentation for the discrimination of
architectural features in ductal proliferative lesions of the breast. J Pathol.
1997;181:374–80.
21. Gao J, McNutt MA, Yi W, Chen J, Gu J. Quantitative morphometry by image
analysis of normal, hyperplastic and cancerous ductal breasts. Anal Quant
Cytol Histol. 2009;31:255–61.
22. Nyirenda N, Farkas DL, Ramanujan VK. Preclinical evaluation of nuclear
morphometry and tissue topology for breast carcinoma detection and
margin assessment. Breast Cancer Res Treat. 2011;126:345–54.
23. Nandakumar V, Kelbauskas L, Hernandez KF, Lintecum KM, Senechal P,
Bussey KJ, et al. Isotropic 3D nuclear morphometry of normal, fibrocystic
and malignant breast epithelial cells reveals new structural alterations. PLoS
One. 2012;7:e29230. doi:10.1371/journal.pone.0029230.
24. Dobbs JL, Ding H, Benveniste AP, Kuerer HM, Krishnamurthy S, Yang W,
et al. Feasibility of confocal fluorescence microscopy for real-time evaluation
of neoplasia in fresh human breast tissue. J Biomed Opt. 2013;18:106016.
doi:10.1117/1.JBO.18.10.106016.
25. Dobbs J, Krishnamurthy S, Kyrish M, Benveniste AP, Yang W, Richards-
Kortum R. Confocal fluorescence microscopy for rapid evaluation of invasive
tumor cellularity of inflammatory breast carcinoma core needle biopsies.
Breast Cancer Res Treat. 2015;149:303–10.
26. Schiffhauer LM, Boger JN, Bonfiglio TA, Zavislan JM, Zuley M, Fox CA. Confocal
microscopy of unfixed breast needle core biopsies: a comparison to fixed and
stained sections. BMC Cancer. 2009;9:265. doi:10.1186/1471-2407-9-265.
27. Parrish A, Halama E, Tilli MT, Freedman M, Furth PA. Reflectance confocal
microscopy for characterization of mammary ductal structures and
development of neoplasia in genetically engineered mouse models of
breast cancer. J Biomed Opt. 2005;10:051602.
28. Tilli MT, Cabrera MC, Parrish AR, Torre KM, Sidawy MK, Gallagher AL, et al.
Real-time imaging and characterization of human breast tissue by
reflectance confocal microscopy. J Biomed Opt. 2007;12:051901.
29. Abeytunge S, Li Y, Larson B, Peterson G, Seltzer E, Toledo-Crow R, et al.
Confocal microscopy with strip mosaicing for rapid imaging over large areas
of excised tissue. J Biomed Opt. 2013;18:61227. doi:10.1117/1.JBO.18.6.061227.
30. Pierce MC, Javier DJ, Richards-Kortum R. Optical contrast agents and
imaging systems for detection and diagnosis of cancer. Int J Cancer.
2008;123:1979–90.
Dobbs et al. Breast Cancer Research  (2015) 17:105 Page 14 of 1431. van de Ven AL, Adler-Storthz K, Richards-Kortum R. Delivery of optical
contrast agents using Triton-X100, part 2: enhanced mucosal permeation
for the detection of cancer biomarkers. J Biomed Opt. 2009;14:021013.
doi:10.1117/1.3090437.
32. Pierce M, Yu D, Richards-Kortum R. High-resolution fiber-optic
microendoscopy for in situ cellular imaging. J Vis Exp. 2011. 10.3791/2306.
33. Rosbach KJ, Shin D, Muldoon TJ, Quraishi MA, Middleton LP, Hunt KK, et al.
High-resolution fiber optic microscopy with fluorescent contrast
enhancement for the identification of axillary lymph node metastases in
breast cancer: a pilot study. Biomed Opt Express. 2010;1:911–22.
34. Thekkek N, Richards-Kortum R. Optical imaging for cervical cancer detection:
solutions for a continuing global problem. Nat Rev Cancer. 2008;8:725–31.
35. Muldoon TJ, Thekkek N, Roblyer D, Maru D, Harpaz N, Potack J, et al.
Evaluation of quantitative image analysis criteria for the high-resolution
microendoscopic detection of neoplasia in Barrett’s esophagus. J Biomed
Opt. 2010;15:026027. doi:10.1117/1.3406386.
36. Thekkek N, Anandasabapathy S, Richards-Kortum R. Optical molecular
imaging for detection of Barrett’s-associated neoplasia. World J
Gastroenterol. 2011;17:53–62.
37. Mueller JL, Harmany ZT, Mito JK, Kennedy SA, Kim Y, Dodd L, et al.
Quantitative segmentation of fluorescence microscopy images of
heterogeneous tissue: application to the detection of residual disease in
tumor margins. PLoS One. 2013;8:e66198.
38. Kyrish M, Dobbs J, Jain S, Wang X, Yu D, Richards-Kortum R, et al. Needle-based
fluorescence endomicroscopy via structured illumination with a plastic,
achromatic objective. J Biomed Opt. 2013;18:096003. doi:10.1117/
1.JBO.18.9.096003.
39. Matas J, Chum O, Urban M, Pajdla T. Robust wide-baseline stereo from
maximally stable extremal regions. Image Vis Comput. 2004;22:761–7.
40. Schondorf H, Naujoks H. Determining the nuclear-area in normal breast
epithelia and in the nuclei of mammary carcinomas. J Cancer Res Clin
Oncol. 1985;109:241–4.
41. Foote FW, Stewart FW. Lobular carcinoma in situ: a rare form of mammary
cancer. Am J Pathol. 1941;17:491–6.
42. Bedard N. Multi-modal imaging techniques for early cancer diagnostics.
Houston, TX, USA: Rice University; 2012.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
